SEC Info - FSD Pharma Inc. - ‘F-3’ on 12/22/23

SEC Info℠

Home

My Interests

Help

Please Sign In

FSD Pharma Inc. – ‘F-3’ on 12/22/23 – ‘EX-23.1’

On: Friday, 12/22/23, at 6:49pm ET · As of: 12/26/23 · Accession #: 1654954-23-15955 · File #: 333-276264

20 References:

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/26/23  FSD Pharma Inc.                   F-3        12/22/23    5:33M                                    Blueprint/FA

Registration Statement by a Foreign Issuer – Securities for a Transaction — Form F-3

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: F-3         Registration Statement by a Foreign Issuer -        HTML    502K 
                Securities for a Transaction                                     
 2: EX-5.1      Opinion of Counsel re: Legality                     HTML     28K 
 3: EX-23.1     Consent of Expert or Counsel                        HTML      5K 
 5: EX-FILING FEES  Filing Fee Table                                HTML     13K 
 4: EX-99.1     Management Information Circular                     HTML     68K

‘EX-23.1’ — Consent of Expert or Counsel

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

EXHIBIT 23.1

Photo -- fsd_ex231img1.jpg

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statement on Form F-3, of our auditor’s report dated March 31, 2023 with respect to the consolidated financial statements of FSD Pharma Inc. and its subsidiaries (the “Company”) as of December 31, 2022 and 2021, and for each of the years in the three-year period ended December 31, 2022, as included in the Company’s Annual Report on Form 20-F for the year ended December 31, 2022, as filed with the United States Securities Exchange Commission.

We also consent to the reference to our firm under the heading “Experts” and “Transfer Agent, Registrar and Auditor” in the Form F-3 Registration Statement.

/s/ MNP LLP

Chartered Professional Accountants

Licensed Public Accountants

December 22, 2023

Toronto, Canada

Dates Referenced Herein and Documents Incorporated by Reference

This ‘F-3’ Filing	Date	Other Filings

Filed as of:	12/26/23
Filed on:	12/22/23
	3/31/23	20-F, 6-K
	12/31/22	20-F
	12/31/21	20-F
		List all Filings

2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/20/24  FSD Pharma Inc.                   424B5       2/16/24    1:863K                                   RDG Filings/FA
12/29/23  SEC                               UPLOAD¶     2/02/24    2:39K  FSD Pharma Inc.

18 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/21/23  FSD Pharma Inc.                   6-K        12/21/23    2:23K                                    Blueprint/FA
12/15/23  FSD Pharma Inc.                   6-K        12/14/23    2:729K                                   Blueprint/FA
12/15/23  FSD Pharma Inc.                   6-K        12/14/23    2:33K                                    Blueprint/FA
12/15/23  FSD Pharma Inc.                   6-K        12/14/23    2:308K                                   Blueprint/FA
12/15/23  FSD Pharma Inc.                   6-K        12/14/23    2:319K                                   Blueprint/FA
12/15/23  FSD Pharma Inc.                   6-K        12/14/23    2:430K                                   Blueprint/FA
12/15/23  FSD Pharma Inc.                   6-K        12/14/23    2:391K                                   Blueprint/FA
11/16/23  FSD Pharma Inc.                   6-K        11/16/23    2:19K                                    Blueprint/FA
11/15/23  FSD Pharma Inc.                   6-K         9/30/23    5:1.1M                                   Newsfile Corp./FA
11/07/23  FSD Pharma Inc.                   6-K        11/07/23    3:61K                                    Blueprint/FA
11/07/23  FSD Pharma Inc.                   6-K        11/06/23    4:83K                                    Blueprint/FA
11/07/23  FSD Pharma Inc.                   6-K        11/06/23    4:3.9M                                   Blueprint/FA
10/24/23  FSD Pharma Inc.                   6-K        10/24/23    4:132M                                   Blueprint/FA
 8/25/23  FSD Pharma Inc.                   6-K         8/02/23    4:64K                                    Newsfile Corp./FA
 3/31/23  FSD Pharma Inc.                   20-F       12/31/22  119:14M                                    Newsfile Corp./FA
 5/26/21  XORTX Therapeutics Inc.           DRS¶        8/12/21   12:3.9M                                   Genesis Filings LLC/FA
 5/05/21  FSD Pharma Inc.                   6-K         5/14/21    3:914K                                   Newsfile Corp./FA
12/06/19  FSD Pharma Inc.                   40FR12B               52:25M                                    Newsfile Corp./FA

↑Top

Filing Submission 0001654954-23-015955 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)